Recent Developments in Targeted Therapies for Non-Small Cell Lung Cancer

Nov 17, 2022 10:52:00 AM / by Champions Oncology posted in Solid Tumor Oncology

Lung cancer is an aggressive malignancy that correspond to approximately 12% of newly diagnosed cases per year and that remains one of the leading causes of cancer-related deaths (21%)[1]. Non-small cell lung cancer (NSCLC) is the most common form of lung cancer and is typically diagnosed at advanced stages[2].

Read More →